Zobrazeno 1 - 10
of 5 003
pro vyhledávání: '"kala"'
Autor:
Subhasish Kamal Guha, Ashif Ali Sardar, Amartya Kumar Misra, Pabitra Saha, Anwesha Samanta, Dipankar Maji, Amitabha Mandal, Punita Saha, Supriya Halder, Kabiul Akhter Ali, Sibajyoti Karmakar, Dipendra Sharma, Ardhendu Kumar Maji
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 1100-1112 (2024)
Abstract Introduction The ongoing visceral leishmaniasis (VL) elimination programme in India is targeting the elimination of the disease VL but not the pathogen. The persistence of hidden parasite pool may initiate a resurgence in suitable conditions
Externí odkaz:
https://doaj.org/article/39e5a45faeae45d0a04d6bc5916515cb
Publikováno v:
Journal of Primary Care Specialties, Vol 5, Iss 2, Pp 119-126 (2024)
Background: Kala-azar, or visceral leishmaniasis, caused by Leishmania donovani, remains a significant health concern in India and other endemic regions. This study aimed to assess the knowledge and practices (KAP) related to kala-azar among the Bedi
Externí odkaz:
https://doaj.org/article/537b005192ba4f93b29fa7ac76ee9b48
Autor:
Amanda Virginia Batista Vieira, Manuela Rocha de Menezes, Pablo Cantalice Santos Farias, Elis Dionísio da Silva, Gilberto Silva Nunes Bezerra, Walter Lins Barbosa Júnior, Zulma Maria de Medeiros
Publikováno v:
Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 30 (2024)
ABSTRACT Visceral leishmaniasis (VL) is a neglected disease that is typical of tropical and subtropical parts of the world and is caused by the trypanosomatid Leishmania donovani complex. This disease is a multifactorial condition that involves paras
Externí odkaz:
https://doaj.org/article/57eee86e58314865aa6e95e7263ec58a
Autor:
Brima M. Younis, Rebecca Wiggins, Eltahir A.G. Khalil, Mohamed Osman, Francesco Santoro, Chiara Sonnati, Ada Keding, Maria Novedrati, Giorgio Montesi, Ali Noureldein, Elmukashfi T.A. Elmukashfi, Ala Eldin Mustafa, Mohammed Alamin, Mohammed Saeed, Khalid Salman, Ahmed J. Suliman, Amin E.A. Musa, Alison M. Layton, Charles J.N. Lacey, Paul M. Kaye, Ahmed M. Musa
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 3, Pp 101310- (2024)
In a recent phase 2a clinical trial, the candidate leishmaniasis vaccine ChAd63-KH was shown to be safe and immunogenic in Sudanese patients with post kala-azar dermal leishmaniasis (PKDL). However, its value as a stand-alone therapeutic was unknown.
Externí odkaz:
https://doaj.org/article/a583923d15cf4d3cb40a6f85f30978df
Autor:
Luis Gustavo Cavalcante Reinaldo, Raimundo José Cunha Araújo Júnior, Thiago Melo Diniz, Rafael de Deus Moura, Antônio José Meneses Filho, Caio Victor Verçosa de Macedo Furtado, Washington Luis Conrado dos Santos, Dorcas Lamounier Costa, Kelsen Dantas Eulálio, Gabriel R. Ferreira, Carlos Henrique Nery Costa
Publikováno v:
Parasites & Vectors, Vol 17, Iss 1, Pp 1-8 (2024)
Abstract Background Visceral leishmaniasis (VL), or kala-azar, is a common comorbidity in patients with AIDS in endemic areas. Many patients continue to experiences relapses of VL despite virological control, but with immunological failure. These pat
Externí odkaz:
https://doaj.org/article/0a0810dc5e634188be760a304b45bca5
Autor:
Md. Mehedi Hasan, Sanghita Banik Proma, Md. Saddam Hossain, Md. Arifuzzaman, Naylla Islam, Md. Abu Bakar Siddique, Amiruzzaman
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that occurs 2–3 years after an apparently successful treatment of visceral leishmaniasis (VL). In rare cases, PKDL occurs concurrently with VL and is characterized by fe
Externí odkaz:
https://doaj.org/article/505e55e50357425ca6f046a4e71dd9d5